Company Profile
Updated: 30-NOV-09Merck and Company Inc.
Exporter
PO Box 100, Whitehouse Station, NJ 08889-0100, United States
(800)225-5675, (908)423-1000, http://www.merck.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Merck and Company Inc. was incorporated in New Jersey and trades on the New York Stock Exchange. The company is a research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of products used to improve human and animal health. Merck and Company has a number of clinical programs across its major research areas: bone, respiratory, immunology and endocrine; cardiovascular; diabetes and obesity; infectious diseases; neuroscience; oncology and vaccines. The company operates two segments: the pharmaceutical segment and the vaccines and infectious diseases segment. Headquartered in Whitehouse Station, N.J., Merck and Company provides its products in the United States and worldwide. The company has production facilities for its human health products at seven locations in the United States and Puerto Rico. Outside the United States, the Merck and Company owns or has an interest in manufacturing plants in Australia, Canada, Japan, Singapore, South Africa, and other countries in Western Europe, Central and South America, and Asia. Among the company's major brands are Singulair, Fosamax, Zocor, Gardasil and Varivax.Manufacturing: Pharmaceuticals and vaccines. Publishing: Health industry based manuals.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Vioxx trial data shows early cardiovascular risk.
NewsRx Health; 12/13/2009; 1047 words; ...years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug...a 43 percent increased risk. Merck introduced Vioxx to the market in...surveillance done by the FDA and the companies. Keywords: Antiinflammatory...
Research Report on BioClinica, Inc. as Speculative Buy.(Report)
Medical Letter on the CDC & FDA; 12/13/2009; 734 words; ...Securities Research, Inc., ("ISR") a Georgia...Report on BioClinica, Inc. (NASDAQ:BIOC) which serves companies in the pharmaceutical...Report rates BioClinica, Inc. as a Speculative Buy...Johnson & Johnson, Merck, and Pfizer. BioClinica...
Merck Announces Quarterly Dividends and New $3 Billion Share Repurchase Program.
Investment Weekly News; 12/12/2009; 643 words; ...Board of Directors of Merck & Co., Inc. declared a quarterly...38 per share on the company's common stock for...75 per share on the company's mandatory convertible...Preferred Stock, Merck & Co. Inc., Other Health, Pharmaceutical...
Investigators at Loyola University Chicago, Medical Department publish new data on cardiovascular.
Biotech Week; 12/9/2009; 897 words; ...long-term rofecoxib (Vioxx; Merck, Whitehouse Station, NJ) treatment...Diclofenac, Drugs, Enzymes, Merck & Company Inc., Molecular Pharmacology, Molecular...Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmacology...
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants.
Vaccine Weekly; 12/9/2009; 1099 words; ...Pharmaceuticals, Inc. (Nasdaq: IDRA) announced that Merck & Co., Inc., through an...December 2006, the companies entered into an...containing the Company's investigational...agreement, the two companies engaged in a two...incorporating both Merck and Idera ...
Recent News Articles
- Recent Merger Settlements In Canada.(Agrium Inc. acquires CF Industries Holdings Inc.)(Merck & Company Inc. accquires Schering-Plough)(Suncor Energy Inc. acquires Ultramar Canada Ltd.)
Mondaq Business Briefing - November 25, 2009 - New findings in life sciences described from Merck & Company, Inc.(Report)
Biotech Week - November 25, 2009 - Research and Markets Offers Report: Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases.(Merck & Company Inc.)(Schering-Plough Corp.)(Wyeth)(Pfizer Inc.)(Roche Holding AG)(Genentech Inc.)(Report)
Wireless News - November 20, 2009 - Scientists at Merck & Company, Inc. release new data on life sciences.
Biotech Week - November 11, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning